Icon

FIRVANQ KIT (nda208910)- (EQ 25MG BASE/ML,EQ 50MG BASE/ML)

VANCOMYCIN HYDROCHLORIDE AZURITY
EQ 25MG BASE/ML,EQ 50MG BASE/ML
Yes Yes
2035-Mar-13 Expired
None None
None No
FIRVANQ is a glycopeptide antibacterial indicated in adults and pediatric patients less than 18 years of age for the treatment of: • Clostridium difficile-associated diarrhea • Enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains).
1 0 1
Total Other Developers None
Drugs with Suitability No
EQ 25MG BASE/ML ** ** - - 1
EQ 50MG BASE/ML ** ** Up - 1
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** **** *** ***** ************ ******* *********** **** **. ***, ******* ****** ***** *****, *******, ******, *****, ***** & *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.